Australian-Singaporean regenerative medicine company Osteopore highlighted progress in its $18.7 million partnership with Singapore’s National Dental Centre and the Agency for Science, Technology, and Research.

The partnership has developed a 3D-printing technology for advanced dental implants, combining patented biological additives and polymer compounds.

Milestones include proving non-cytotoxicity and enhanced bone regeneration potential. Moving forward, in vivo studies will evaluate efficacy.